Clinical Trial Update: Paclitaxel-Avelumab for Angiosarcoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial investigating the combination of paclitaxel and avelumab for metastatic angiosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma

Drugs mentioned

• Avelumab (avelumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sung Yong Oh | Conditions: Angiosarcoma Metastatic | Phase 2 | Status: UNKNOWN